SF3B1 and cancer: Furthermore, a tumorsphere formation assay (used to quantify the proliferation capacity of cancer stem-like progenitor cells) revealed that SF3B1 blockade drastically decreased the number and area of tumorspheres in both cell lines (Fig. 5f).